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The effects of equipotent concentrations (1.5 times atrial-His conduction at paced heart rates of 180 and 
minimum alveolar concentration) of the inhalational 200 beats/min when compared to chloralose anes- 
agents halothane, enflurane, and isoflurane on sinus thesia and the other two inhalational agents 
node function, and atrioventricular (A-V) conduction (P -C .OOl). Atrioventricular refractoriness was im- 
and refractoriness were compared with chloralose paired by enflurane (P < .OOl) and halothane 
anesthesia in 49 mongrel dogs. Sinus node function (P < .05), but not isoflurane, when compared with 
was assessed using corrected sinus node recovery chloralose anesthesia. Ventricular-His conduction 
time. Atrial-His and His-ventricular conduction times was not altered by any of the agents. The authors 
were measured at paced heart rates of 150.180. and conclude that enflurane is associated with a greater 
200 beatsimin, and A-V refractoriness was impairment of A-V conduction and refractoriness 
assessed by Wenckebach periodicity. There was no than halothane or isoflurane, and that these changes 
evidence that sinus node function was impaired by are related to the anesthetic agent *and not the 
any of the inhalational agents. Enflurane anesthesia anesthetic state. 
was associated with a significant prolongation of c 1988 by Grune & Stratton. Inc. 
A N UNDERSTANDING of the effects of the three commonly used inhalational 
agents, halothane, isoflurane, and enflurane, on 
cardiac electrophysiology is important in order to 
help explain and treat dysrhythmias that may 
occur when these agents are used during anes- 
thesia. Although changes in cardiac conduction 
may not often be apparent when these agents are 
used alone, the potential exists for interactions 
with other cardiac depressant drugs, particularly 
the calcium channel blockers’-3 and beta-block- 
ers.4 
Previous experimental work has docu- 
mented that in vitro, halothane, enflurane, and 
isoflurane depress sinus node function similarly 
when equipotent concentrations are compared.’ 
Markedly different responses in heart rate have 
been seen, however, when the drugs are studied 
clinically.6 There are no previous reports that 
have examined sinus node function with the 
different inhalational agents in an intact animal 
model. 
work with inhalational agents comparing 
increasing anesthetic levels of a particular agent 
found prolongation of A-V conduction with halo- 
thane’ and enflurane,* but not with isoflurane.’ 
More recent work by Atlee et al” comparing 
conscious and anesthetized states using chroni- 
cally instrumented animals demonstrated isoflu- 
rane to be the least depressant of the inhalational 
anesthetics, while enflurane and halothane pro- 
duced equal depression of A-V conduction times. 
They also concluded that the depression of myo- 
cardial conduction observed was probably due to 
the anesthetic state and not to increased levels of 
the anesthetic per se.” 
Reported changes of atrioventricular (A- 
V) conduction using inhalational agents have 
varied according to the model used. Previous 
The purposes of this experiment were to: 
(1) Investigate the effects of the inhalational 
agents on A-V conduction and A-V node refrac- 
toriness in the anesthetized animal, and to com- 
pare these effects to chloralose anesthesia, which 
does not alter A-V function,” and (2) examine 
the effects of the inhalational agents halothane, 
enflurane, and isoflurane on sinus node function 
in an intact model. 
METHODS 
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Unpremeditated mongrel dogs of either sex (weight 
range, 8 to 15 kg) were divided into four groups, each 
anesthetized with a different anesthetic agent. Dogs in group 
1 (n = 12) were anesthetized with intravenous chloralose, 
using 120 mg/kg for induction and 50 mg/kg/h for mainte- 
nance. This group acted as the control group. The other dogs 
were anesthetized with one of the inhalational agents halo- 
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thane, enflurane, or isoflurane, and maintained throughout 
the experiment at a level of 1.5 times the minimum alveolar 
concentration (MAC) for that agent. Group 2 (n = 12) 
animals were anesthetized with 1.3% halothane (MAC = 
0.87%), group 3 (n = 13) were anesthetized with 3.3% enflu- 
rane (MAC = 2.2%), and group 4 (n = 12) were anesthe- 
tized with 2.3% isoflurane (MAC = l.S%).‘* End-tidal anes- 
thetic concentrations were measured using a Perkin-Elmer 
Model 1100 medical gas analyzer (Pomona, CA). No muscle 
relaxants or other drugs were administered to the dogs. All 
dogs underwent endotracheal intubation and were ventilated 
using a Bain circuit with a fresh gas flow of 3 L/min of air 
and oxygen. 
After induction of anesthesia, femoral artery and vein 
catheters were inserted. Arterial pressure was measured 
using Gould-Statham pressure transducers and recorded on a 
Gould ES-1000 recorder (Cleveland). A quadripolar elec- 
trode catheter with an interelectrode distance of 10 mm was 
inserted via the right external jugular vein and positioned 
such that the proximal electrode pair were in the high right 
atrium (to allow atria1 pacing) and the distal electrode pair 
were used for recording of the atria1 electrogram. A bipolar 
catheter was inserted via the left internal carotid artery and 
advanced toward the root of the aorta until optimum His- 
bundle recordings were obtained as displayed on an oscillo- 
scope. A right thoracotomy was then performed exposing the 
heart to allow bipolar plaque electrodes to be sutured to the 
right atrium and the apex of the right ventricle to deliver 
extra stimuli for use during further experimentation on the 
dogs. The ECG, atria1 electrogram, and His-bundle electro- 
gram were continuously displayed using a Tektronix Digital- 
izing Oscilloscope (Beaverton, OR). Intermittent recordings 
of the above waveforms and blood pressure were made at 
intervals during the experiment using a multichannel re- 
corder (Gould ES-1000) filtered at 30 to 200 Hz to allow 
calculation of the information presented below (Fig 1). 
All dogs were ventilated to normocarbia by adjusting 
the tidal volume to maintain arterial PaCO, within the range 
of 35 to 40 mmHg. The dogs were hydrated using lactated 
Ringers solution at 2 ml/kg/h following a loading dose of 5 
to 10 mL/kg. Esophageal temperature was maintained 
between 36 and 38°C using an infrared heater as necessary. 
Arterial blood gases including pH, plus sodium and potas- 
sium, were measured at intervals during the experiment and 
maintained within the physiologic range. The pH was main- 
tained between 7.35 and 7.45 using sodium bicarbonate as 
required (0 to 30 mEq/h), and the serum potassium between 
3.5 and 4.5 mmol/L by potassium infusion (0 to 12 mEq/h). 
All dogs were allowed to stabilize for 30 minutes after the 
thoracotomy before the experimental procedure was com- 
menced. 
Electrophysiologic Measurements 
The following electrophysiologic measurements were 
made: Corrected sinus node recovery time, atrial-His (A-H) 
interval with the animals atrially paced at 150, 180, and 200 
beats/mm, Wenckebach periodicity (WB), and His-ventricu- 
lar (H-V) conduction time at 150, 180, and 200 beats/mitt. 
Corrected sinus node recovery time (CSNRT) was measured 
by atria1 pacing with the high right atria1 electrode at three 
different heart rates above the spontaneous sinus rate of 150, 
Fig 1. Simultaneous surface ECG (lead II), His- 
bundle electrogram (showing A-H and H-V intervals), and 
atrial electrogram recorded at paper speed of 260 mm/set 
during atrial pacing (stimulus artifact is also shown). 
180, and 200 beats/min for 30 seconds with a one minute rest 
between each pacing period. Sinus node recovery time was 
determined as the time from the last paced P wave to the first 
sinus escape beat seen on the atria1 electrogram. Corrected 
sinus node recovery time was then calculated as the sinus 
node recovery time minus the pre-pacing, sinus P-P interval. 
The longest recovery time at the three pacing rates was 
recorded as the corrected sinus node recovery time.” 
The A-H interval and the H-V interval were recorded 
from the His-bundle electrogram at a paper speed of 250 
mm/s. The A-H interval was measured from the beginning of 
atria1 activity to the beginning of the His potential, and the 
H-V interval as the time from the beginning of the His 
potential to the beginning of the ventricular electrogram in 
the His-bundle recording. All dogs were paced at three 
different rates: 150, 180, and 200 beats/min, with both A-H 
and H-V intervals recorded following 30 seconds of pacing. 
Wenckebach periodicity was determined by atrially 
pacing from sinus rhythm and decreasing the paced cycle 
length by 10 msec every ten beats until the Wenckebach 
phenomenon occurred. The cycle length at which the 
Wenckebach phenomenon first occurred was recorded as 
WB.14 
Atria1 pacing was achieved with a Grass 588 stimula- 
tor, using a square wave impulse with a duration of 2 msec. 
The stimulating current used was three times the diastolic 
threshold determined at the beginning of each experiment. 
The data were analyzed using non-paired Students t 
test after an analysis of variance. All P values are reported 
using the Bonferroni correction for multiple comparisons 
when indicated. The data for A-H conduction were compared 
to chloralose; for the other measurements, between-group 
comparisons for inhalation agents were made. The interrela- 
tionships between the A-H intervals were further examined 
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Table 1. Effects of Anesthetic Aaents on Mean Blood Pressure, Heart Rate, and CSNRT 




so f 20 76 + 16 
119 * 19 105 * lo* 
102 + 52 70 t 27 
EllflllraC4 lsoflurane 
61 k 13t 79 * 13 
97 + 6t 99 & St 
71 *59 84 f 52 
Abbreviations: BP, blood pressure; HR. heart rate. 
NOTE: All values are mean 2 standard deviation. 
??f < .05 compared to chloralose. 
tP < .OOl compared to chlwalose. 
by profile analysis. Profile analysis is a combination of tests 
which in this experiment examines for a main effect for 
differences among anesthetics, a main effect for changes in 
heart rate, and an interaction between anesthetics and heart 
rate. The interactive effect or test for parallelism is analogous 
to a repeated measures analysis of variance.” 
RESULTS 
The heart rate and blood pressure of the 
four groups taken after the 30-minute stabiliza- 
tion period are shown in Table 1, along with the 
corrected sinus node recovery times. There are no 
differences in corrected sinus node recovery 
times among the three inhalational agents. The 
measurements for A-H 150, A-H 180, A-H200, 
WB, H-V150, H-V180, and H-V200 are shown 
in Table 2. Five of the dogs anesthetized with 
enflurane exhibited the Wenckebach phenome- 
non when atrially paced at 180 beats/min. In 
these dogs, the A-H interval recorded was the 
interval immediately prior to the dropped beat, 
as this is the longest A-V nodal conduction for 
this heart rate. This phenomenon did not occur 
with halothane or isoflurane. All results are 
compared with chloralose. There was no differ- 
ence in the A-H interval at the slowest heart rate 
between the inhalational agents and chloralose. 
At higher paced rates of 180 and 200 beats/min, 
A-H intervals in those animals receiving enflu- 
rane anesthesia were significantly prolonged 
when compared to those receiving chloralose 
anesthesia (Fig 2). Further analysis of the A-H 
intervals using profile analysis demonstrated 
both a main and interactive effect when animals 
receiving enflurane are compared with those 
receiving chloralose. In addition, an interactive 
effect was demonstrated when the A-H intervals 
in animals receiving halothane are compared 
with those receiving chloralose (P = .045). This 
suggests that the two slopes of the lines compar- 
ing the increase in A-H interval in animals 
receiving halothane and those receiving chlora- 
lose are not parallel as the heart rate is increased. 
The Wenckebach cycle length (WB) was pro- 
longed in those dogs anesthetized with enflurane 
and halothane, but not isoflurane when com- 
pared with chloralose. 
DISCUSSION 
This study compared the effects of the 
inhalation agents halothane, enflurane, and iso- 
flurane on A-V conduction, with reference to 
chloralose, an anesthetic which has minimal 
effects on A-V nodal function.” Atrioventricular 
conduction becomes prolonged with increasing 
heart rate16; therefore, it is important to deter- 
mine A-H and H-V intervals at different, paced 
heart rates. In this way, comparisons at similar 
and increasing heart rates can be examined. This 
study did not attempt to determine the exact 
mechanisms responsible for alterations in A-V 
Table 2. Effects of Anesthetic Agents on WB, A-H. and H-V Intervals (msec) 
Chloralosa Halothane Enflurane lsoflurane 
WB 247 f 28 283 f 39’ 306 k 41t 264 f 28 
A-H 150 89 zt 24 96 f 27 110 f 46 91 + 16 
A-H 180 96 + 27 110 f 28 200 f 104t 106 f 21 
A-H 200 104 * 33 136 f 40 256 f 148t 131 f 41 
H-V 150 36 k 4 36 + 6 35 f 3 39 f 9 
H-V 180 36 f 5 35 f 5 35 f 3 38 + 10 
H-V 200 36 k 6 39 * 10 34 f 3 38 f 10 
NOTE: All values are means + standard deviation. 
??P < .05 compared to chlwalose. 
tP < ,001 compared to chloralose. 













Fig 2. Change in A-H inter- 
val with increasing paced heart 
rate in dogs undergoing halo- 
thane, enflurane, isoflurane, 
and chloralose anesthesia. All 
Il. I ' I - I m I u I ' I m 1 
150 160 170 180 190 200 210 
Paced Heart Rate (b/kin) 
values are mean + SEM. *p<O.OOl compared with chloralo&e 
conduction, but rather to determine the effects of 
the inhalational agents as they may be used in 
the clinical setting, ie, without autonomic block- 
ade. 
Enflurane impaired A-V conduction and 
refractoriness when compared with chloralose 
anesthesia. This effect of enflurane on the A-V 
node was demonstrated by a greater prolongation 
of the A-H interval with enflurane and an 
increased cycle length at which Wenckebach 
periodicity occurred. Evidence was also found 
that halothane impairs A-V refractoriness as 
shown by the increased cycle length at which 
Wenckebach periodicity occurred. Although 
there was no change in A-H interval when ani- 
mals anesthetized with halothane were compared 
with chloralose, profile analysis demonstrated 
that a significant interactive effect occurred 
(P = .045). This suggests that the rate of change 
of A-H interval with increasing heart rate is not 
the same when the two drugs are directly com- 
pared. There was no evidence from this study 
that isoflurane affected A-V conduction. 
Wenckebach periodicity is a different mea- 
surement and correlates with other measure- 
ments of A-V node refractoriness.” The increase 
in Wenckebach cycle length seen with halothane 
and enflurane shows that the refractory period of 
the A-V node is prolonged compared with chlora- 
lose anesthesia. 
In this study, enflurane produced a greater 
decrease in blood pressure than chloralose or the 
other inhalational agents. This is in agreement 
with its known direct effects on myocardial con- 
tractility’* and its indirect effects mediated by 
suppression of the baroreceptor reflex.” This is 
unlikely to have caused the prolongation’ of the 
A-H interval or the increase in Wenckebach 
cycle length, as within each anesthetic group 
there was no correlation between blood pressure 
and A-H interval or blood pressure and Wencke- 
bath cycle length. With enflurane the results 
were as follows: BP v A-H 150 (? = .13, P > .2); 
BP v A-H 180 (? = .02, P >.6); BP v A-H 200 
(? = .08, P > .3); BP, v WB (3 = .06P > .4). 
Previous investigators have examined 
changes in A-V conduction produced by the 
inhalational anesthetics using either dose-related 
changes with increasing anesthetic concentra- 
tions7’9 or by determining changes from the 
awake state in chronically instrumented ani- 
mals.” Differing results have been reported for 
the various agents depending on the model stud- 
ied; the results for these experiments have been 
similar, but they have not been in total agree- 
ment. 
The essential findings of the previous stud- 
ies are summarized in Table 3. In none of these 
studies was Wenckebach periodicity measured. 
Taken collectively, three early, single-agent, 
dose-response studies suggested that enflurane 
may have a greater depressant effect on A-V 
conduction thanthe other inhalational agents.7-9 
However, this was not seen in the later study of 
Atlee et al when a conscious control state was 
used.” Using chronically instrumented dogs, 
they found that both enflurane and halothane 
produced a similar prolongation of the A-H 
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Table 3. Previous Studies of Anesthetic Agents and A-V Conduction 






MAC Equivalent Basal HR 200 beats/min AH-V Interval ABP 
1977 Atlee 61 Alexander’ Acute Hal 1.25 MAC 2.00 MAC 
2.75 MAC 
1977 Atlee & Rusy* Acute Enfl 1 .O MAC 1.5 MAC 2.0 1 ;I u 1 
1979 Blitt et al’ Acute lsof 1.25 MAC 2.0MAC - 40%1 
2.5 MAC - 42%1 
1986 Atlee et al” Chronic awake Awake Hal 1.2 ??
Hal 1.7 i 15%1 
Hal 2.3 35%1 
Enfl 1.2 ; 1 i ??
Enfl 1.7 27%1 
Enf12.3 ; 1 !l 44%1 
lsof 1.2 * 
lsof 1.7 
lsof 2.3 
I 1 22%l 
- i 41%1 
Abbreviations: Hal, halothane; Enfl, enflurane; Isof, isoflurane. 
Symbols: -, no change from control; 1, increase compared with control; f t, further increase compared to control; ??, A from Anes 
1.2 MAC. 
interval. In that study, however, basal heart rates 
were only measured as spontaneous heart rates, 
and the effect of higher paced heart rates was not 
investigated; thus, the results of the present study 
and that of Atlee et al” are not directly compara- 
ble. 
The use of chloralose in the present experi- 
ment allowed for comparison of the effects of 
equivalent anesthetic concentrations of the inha- 
lational agents to another anesthetic (which does 
not affect A-V conduction or A-V refractori- 
ness).” This was useful as it had been suggested 
that the changes in A-V conduction with the 
inhalational anesthetic agents were due to the 
anesthetic state rather than the individual 
agents.” Possible mechanisms for the changes in 
A-V conduction and refractoriness include both 
a direct effect of the agent and an indirect effect 
due to a decrease in sympathetic tone due to that 
agent. Differentiation of these two mechanisms 
was not possible with this experimental model. It 
is possible that the different experimental model 
of an open chest animal rather than a closed 
chest one as described in previous studies may 
also influence some of the results. It is apparent 
from the data presented in this experiment that 
enflurane has a more depressant effect on A-V 
conduction and refractoriness than either isoflu- 
rane or halothane at equipotent concentrations 
(1.5 x MAC), levels that are likely to be used 
clinically. In addition, there have been no previ- 
ous data comparing equivalent anesthetic con- 
centrations of the inhalational agents at increas- 
ing paced heart rates. The results from the 
present experiment at a heart rate of 150 beats/ 
min demonstrates that there is no difference in 
A-H conduction when the inhalational agents are 
compared to chloralose. Impaired A-H conduc- 
tion in enflurane-anesthetized animals is only 
apparent at increased heart rates when conduc- 
tion through the node is already prolonged. 
Sinus node function is difficult to assess in 
the intact animal as evidenced by the wide stan- 
dard deviations in the data presented. Previous in 
vitro studies revealed that halothane, enflurane, 
and isoflurane caused approximately equal 
depression of sinus node function (as shown by a 
decrease in the slope of phase 4 and phase 0 
depolarization and a decrease in the action 
potential duration). 5 The depression of sinus 
node function seen in vivo is easily reversed by 
epinephrine. The effects of chloralose on sinus 
node function have not been documented, there- 
fore only a within-group comparison of the inha- 
lational agents was possible. Corrected sinus 
node recovery time is a measure of sinoatrial 
automaticity and function.” Although corrected 
sinus node recovery time is prolonged by increas- 
ANESTHETIC EFFECTS ON CARDIAC CONDUCTION 
ing heart rate, in the canine model the maximum 
prolongation occurs at a heart rate of 200 beats/ 
min.21 There are no data on corrected sinus node 
recovery time values in the awake dog. Informa- 
tion from dogs anesthetized with pentobarbital 
undergoing sinus node injury by crushing has 
demonstrated that corrected sinus node recovery 
time values increase from 104 f 13 msec before 
sinus node injury to 359 + 34 msec at a rate of 
200 beats/min after sinus node injury.2’ Clearly 
the values presented in the present experiment do 
not suggest any evidence of sinus node dysfunc- 
tion at the concentrations used. Subtle changes in 
sinus node function compared with the awake 
state, and autonomic influences on sinus node 
function in the presence of inhalational agents 
have not been reported. 
193 
In conclusion, these data suggest that when 
equipotent anesthetic concentrations of inhala- 
tional agents are compared in the canine model, 
enflurane has a more deleterious effect on A-V 
conduction and refractoriness than halothane or 
isoflurane. The difference between the inhala- 
tional agents when compared to chloralose anes- 
thesia makes it unlikely that the anesthetic state 
is solely responsible for the changes observed. In 
addition, preliminary data on sinus node function 
at the same anesthetic concentration of inhala- 
tional agents does not suggest that any signifi- 
cant dysfunction occurs. 
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